Saika Farook | Microbiology | Excellence in Research Award

Published on by Cell Biologist

Assist. Prof. Dr. Saika Farook | Microbiology | Excellence in Research Award

Assist. Prof. Dr. Saika Farook | Ibrahim Medical College | Bangladesh 

Dr. Saika Farook is a dedicated microbiologist from Bangladesh with a strong academic background and extensive experience in infectious diseases and microbiology. She earned her MD in Microbiology from BIRDEM Academy (BSMMU) and has been actively involved in research and teaching. Currently, she serves as an Assistant Professor at Ibrahim Medical College and an Adjunct Faculty at BRAC University. Dr. Farook’s work centers on identifying and combating bacterial infections, especially Burkholderia pseudomallei, the causative agent of melioidosis, a neglected tropical disease. She has contributed significantly to both clinical diagnostics and molecular research and has been recognized as a speaker at international conferences. Saika’s commitment to bridging laboratory findings with clinical practice makes her a valuable asset in the field of medical microbiology. She is a life member of Bangladesh Society of Medical Microbiologists and contributes globally to the American Society for Microbiology.

Publication Profile: 

Orcid
Scopus

Education:

Dr. Saika Farook completed her Bachelor of Medicine and Bachelor of Surgery (MBBS) from Noakhali Medical College, affiliated with Chittagong University. She then pursued a Doctor of Medicine (MD) in Microbiology from BIRDEM Academy under Bangabandhu Sheikh Mujib Medical University (BSMMU), graduating . Her early education includes O’ Levels from Shaheen English Medium School with 8 A’s and Higher Secondary Certificate (H.S.C.) from Rajuk Uttara Model College, Dhaka. Her rigorous academic journey demonstrates a consistent pursuit of excellence, culminating in advanced specialization in microbiology, infectious diseases, and molecular diagnostics. She has also enhanced her skills through multiple workshops on bioinformatics, bacterial genomics, and infection prevention.

Experience:

Dr. Farook has accumulated rich professional experience in both clinical and academic settings. She has been an Assistant Professor at Ibrahim Medical College’s Department of Microbiology. She holds an adjunct faculty role in the Department of Mathematics and Natural Science at BRAC University. Previously, she served as Junior Consultant at DMFR Molecular Lab & Diagnostics and worked as a Virologist during the critical COVID-19 period. She completed a rigorous MD residency in Microbiology at BIRDEM Academy and served as an intern doctor at Jananeta Nurul Haque Adhunik Hospital. Her roles highlight strong clinical acumen paired with research-driven teaching, enhancing laboratory diagnostic techniques and molecular microbiology.

Research Focus:

Dr. Saika Farook’s research primarily targets Burkholderia pseudomallei, the bacterium responsible for melioidosis, focusing on its detection, molecular epidemiology, and antimicrobial susceptibility. She has contributed to developing novel diagnostic methods, such as Loop Mediated Isothermal Amplification assays and selective culture media. Her research also explores the clinical epidemiology of infectious diseases, including latent tuberculosis and IgG4-related disorders. Funded by both Ibrahim Medical College and the Ministry of Health, her ongoing projects delve into molecular epidemiology and clinical sample analysis from tertiary hospitals in Dhaka. Her work bridges molecular diagnostics and public health, addressing gaps in disease recognition in Bangladesh. Dr. Farook has actively presented her findings in national and international forums, reflecting her commitment to advancing microbiological research with real-world clinical applications.

Publications Top Notes: 

  1. An improved Loop Mediated Isothermal Amplification based assay for the rapid Identification of Genomic DNA of Burkholderia pseudomallei

  2. Melioidosis cases detected in Dhaka, Bangladesh: a positive impact of 3rd South Asian Melioidosis Congress

  3. Effectiveness of a novel selective medium “Modified MacConkey Agar for Burkholderia” for isolation of Burkholderia pseudomallei

  4. Knowledge on melioidosis among healthcare workers of Bangladesh

  5. Melioidosis: Still Unresolved and Undetected in Unexplored Regions

  6. Interferon Gamma Release Assay for Latent Tuberculosis Screening in High TB-Endemic Region: A Retrospective Study

  7. Use of Comparative Genomics to resolve an unusual case of Aminoglycoside Susceptibility in Burkholderia pseudomallei

  8. Localized Disseminated Tuberculosis in a 3 year’s old Bangladeshi boy: A Case Study

  9. Modified MacConkey agar: a simple selective medium for isolation of Burkholderia pseudomallei from soil

  10.  Phylogeographic characterization of Burkholderia pseudomallei isolated from Bangladesh

Conclusion:

In conclusion, Dr. Saika Farook is a highly suitable candidate for the Research for Excellence in Research Award. Her strong academic background, significant research contributions in microbiology and infectious diseases, and active participation in academic and scientific communities demonstrate her dedication and impact in her field. With some strategic focus on expanding international collaborations, translational research, and leadership in mentoring, she could further strengthen her candidacy. Overall, her achievements and ongoing commitment to advancing medical microbiology make her an excellent contender for recognition through this award.

Yuxin Peng | Cell Adhesion Mechanisms | Best Researcher Award

Published on by Cell Biologist

Prof. Yuxin Peng | Cell Adhesion Mechanisms | Best Researcher Award

Prof. Yuxin Peng | Zhejiang University | China

Dr. Yuxin Peng is a distinguished researcher and educator in the field of biomedical and exercise science engineering. Currently serving as a ZJU 100 Young Professor at Zhejiang University, China, he has made significant strides in developing flexible sensors, smart wearable systems, and human–machine interaction technologies. With a Ph.D. and postdoctoral training at the National University of Singapore, his research integrates cutting-edge materials science, biomechanics, and AI-driven health monitoring systems. His work has been consistently published in high-impact journals like Science Advances, Advanced Science, IEEE Transactions, and Soft Robotics, reflecting both depth and innovation. Dr. Peng’s contributions are not only academic but also practical, with several of his innovations applied in rehabilitation, sports science, and robotics. His dedication and cross-disciplinary expertise make him a strong candidate for recognition such as the Best Researcher Award.

Publication Profiles: 

Orcid
Scopus

Education:

Dr. Yuxin Peng received his doctoral degree (Ph.D.) in an engineering-related discipline, laying a strong foundation in biomedical engineering, biomechanics, and sensor technologies. His early academic pursuits were rooted in multidisciplinary innovation, merging engineering principles with human physiology and robotics. To further deepen his scientific understanding, he pursued postdoctoral research at the prestigious National University of Singapore, focusing on biomedical systems and smart rehabilitation. During his academic training, Dr. Peng built expertise in wearable sensors, motion tracking systems, and soft robotics—technologies that play a crucial role in personalized healthcare and intelligent rehabilitation. His education trajectory demonstrates both depth and diversity, preparing him to address complex biomedical challenges with integrated, high-tech solutions. It also laid the groundwork for his future leadership roles and impactful research career at Zhejiang University, where he now mentors young researchers and leads innovation in health engineering.

Experience:

Dr. Yuxin Peng has built an impressive academic and research career spanning over a decade. He has been a ZJU 100 Young Professor at Zhejiang University, affiliated with the Institute of Exercise Science and Health Engineering. In this role, he leads interdisciplinary research projects in wearable technology, flexible sensors, and human motion analysis. Prior to this, he served as a Research Fellow at the Department of Biomedical Engineering, National University of Singapore, where he focused on intelligent health systems and rehabilitation technologies. His hands-on experience in global, high-tech research environments has allowed him to develop collaborations with experts in robotics, materials science, and medical engineering. He has supervised numerous projects and students, while continuously publishing in high-impact journals. His experience demonstrates a rare blend of academic rigor and real-world application, making him a leader in human-centered biomedical innovation and smart rehabilitation systems.

Research Focus:

Dr. Yuxin Peng’s research focuses on wearable systems, smart sensors, soft robotics, and biomedical signal processing for human motion monitoring and rehabilitation. His work addresses real-world problems such as gait analysis, joint motion detection, force sensing, and rehabilitation assistance. By integrating AI, flexible electronics, and biocompatible materials, he develops high-performance sensors and intelligent exosuits for applications in sports science, elderly care, and physical therapy. Notable innovations include graphene-based aerogels, hydrogel biosensors, and multi-feature neural networks for gesture recognition. His lab has also contributed to optical waveguide sensors, virtual reality rehabilitation, and MI-controlled exoskeletons. The overarching goal of his work is to enable non-invasive, real-time, and personalized health monitoring through smart technology. By pushing the boundaries of soft, adaptive, and human-interactive systems, Dr. Peng’s research is at the forefront of the next generation of intelligent biomedical engineering solutions.

Publications Top Notes:

  1. Hydroplastic Foaming of Graphene Aerogels and AI Tactile Sensors – Science Advances

  2. Underwater Instant Adhesive Hydrogel Interfaces for Robust Biosensing – Advanced Science

  3. Flexible Segmented Assemblable Fiber Optic Sensor for Multi-Joint Monitoring – Soft Robotics (Accepted)

  4. Calibration-Free Optical Waveguide Bending Sensor for Soft Robots – Soft Science

  5. Distributed Plantar 3D Force Measurement System – Sensors and Actuators A

  6. Superelastic Graphene Nanofibrous Aerogels for Intelligent Sign Language – Small

  7. Omnidirectional Soft Bending Sensor for Joint Monitoring – IEEE TIE

  8. Shank-RIO: Ranging-Inertial Odometry for Gait and Positioning – IEEE TIM

  9. Exosuit with Bidirectional Hand Support via Gesture Recognition – IEEE TNSRE

  10.  Advances in Flexible Bending Sensors and Applications – IJ Smart & Nano Materials

Conclusion:

In conclusion, Dr. Yuxin Peng exhibits all the qualities of a top-tier, award-worthy researcher. His work is characterized by scientific rigor, high-impact publication, and a vision for solving real-world healthcare challenges using cutting-edge sensor and robotics technologies. As a respected academic at Zhejiang University with a solid international research background, Dr. Peng has already contributed significantly to wearable health tech and rehabilitation sciences. His ability to combine soft material innovation, artificial intelligence, and biomechanics into novel human-machine interaction systems places him at the forefront of biomedical engineering research. While there is room for growth in the areas of commercialization and global academic engagement, his career trajectory, research excellence, and societal relevance of his innovations make him a highly deserving candidate for the Best Researcher Award.

John Carethers | DNA Repair | Best Researcher Award

Published on by Cell Biologist

Prof. John Carethers | DNA Repair | Best Researcher Award

Prof. John Carethers, UC San Diego, United States

Dr. John M. Carethers is a distinguished academic leader and physician-scientist in the field of gastroenterology and cancer genetics. Serving as Vice Chancellor for Health Sciences at the University of California San Diego, he also holds professorial appointments in both the School of Medicine and the Herbert Wertheim School of Public Health. His extensive contributions to colorectal cancer research, health disparities, and tumor biology have earned him national recognition. Dr. Carethers is renowned for his work on DNA mismatch repair mechanisms and their implications in cancer progression and treatment responsiveness. With a prolific publication record and influential roles in medicine and science policy, he stands as a model for translational research excellence. His commitment to mentorship and health equity further underscores his holistic impact on the field of medicine. Dr. Carethers continues to push scientific boundaries while advocating for inclusive healthcare solutions.

Publication Profile: 

Google Scholar

Scopus

Education:

Dr. Carethers completed his undergraduate education at Wayne State University, earning a B.S. in Biological Sciences with a minor in Chemistry (1981–1985). He graduated with distinction and was a recipient of the Michigan State Competitive Scholarship. He continued at Wayne State University School of Medicine, where he earned his M.D. with High Distinction in 1989. His academic performance was recognized with multiple honors including the Dean’s Academic Achievement Award and awards from the Black Medical Association. Dr. Carethers then completed an internship in Internal Medicine at Massachusetts General Hospital (1989–1990), a prestigious Harvard-affiliated institution, under the guidance of Chief of Medicine Dr. John T. Potts. His medical and research training provided the foundation for a career focused on gastrointestinal disorders, tumor genetics, and health disparities, particularly in colorectal cancer. His formative years reflect academic excellence and an early commitment to advancing medicine through both practice and research.

Professional Experience:

Dr. John M. Carethers currently serves as the Vice Chancellor for Health Sciences at the University of California San Diego. He is also a Distinguished Professor in the Department of Medicine and an Adjunct Professor in the School of Public Health. His career has spanned prestigious academic roles, including clinical and research leadership in gastroenterology, particularly focused on colorectal cancer. A physician-scientist, Dr. Carethers has served in roles that bridge bench science and clinical application, contributing significantly to translational medicine. His academic journey includes mentorship of emerging scientists, leadership in national research initiatives, and board participation in scientific organizations. His experience also encompasses major roles in cancer health disparities research, aiming to close gaps in outcomes across racial and socioeconomic lines. Dr. Carethers is a prolific researcher and thought leader whose experience enhances institutional vision, diversity, and health equity. His impactful career exemplifies a dedication to excellence in science and medicine.

Awards and Honors:

Dr. Carethers has been recognized with numerous academic and professional honors throughout his career. As an undergraduate, he received the Michigan State Competitive Scholarship and was inducted into the Golden Key National Honor Society. During medical school, he earned the Dean’s Academic Achievement Award and awards from the Black Medical Association in 1986 and 1987. Over time, he has been widely honored for his contributions to colorectal cancer research, healthcare leadership, and advocacy for health equity. His published work has been highly cited and influential in advancing our understanding of tumor genetics and mismatch repair. He has received numerous invitations for keynote talks and appointments to national research boards and committees. Dr. Carethers’s career has been marked by his commitment to mentoring, scholarly productivity, and advocacy, positioning him as a leader and role model in academic medicine. These honors underscore his national and global influence in health sciences.

Research Focus:

Dr. John M. Carethers’s research primarily focuses on colorectal cancer, particularly mechanisms of tumor progression, genetic and epigenetic alterations, and mismatch repair (MMR) deficiency. He has deeply explored how MMR status influences treatment responses, especially to chemotherapy agents like 5-fluorouracil. A key aspect of his work includes identifying biomarkers for cancer prognosis and understanding familial cancer syndromes, including Lynch syndrome and polyposis syndromes. His studies also delve into the molecular mechanisms underlying microsatellite instability (MSI) and its role in genomic instability. Importantly, Dr. Carethers is a leading voice in cancer health disparities, examining how social, economic, and biological factors impact outcomes among underrepresented populations. His research bridges basic molecular science with clinical applications, enabling personalized approaches to treatment and surveillance. Through his work, he contributes to reducing cancer burden and mortality while promoting health equity in vulnerable communities—making him a pioneer in both biomedical research and public health.

Publications Top Notes:

  1.  Experimental and clinical observations on frostbite

  2.  The epidemiology of methicillin-resistant Staphylococcus aureus in a burn center

  3.  Extraintestinal Manifestations of Crohn’s Disease

  4.  Human chromosome 3 corrects mismatch repair deficiency in colon tumor cells

  5.  Delayed gastric emptying after laparoscopic vagotomy

  6.  Mismatch repair and the G2 cell cycle checkpoint

  7. In vitro assay for screening hMLH1 and hMSH2 mutations

  8.  Massive secretory diarrhea and pseudo-obstruction in Crohn’s disease

  9.  Mismatch repair blocks clonal expansion after DNA damage

  10.  Localization of Bannayan-Riley-Ruvalcaba syndrome gene to chromosome 10q23

Conclusion:

In conclusion, Dr. John M. Carethers embodies the highest standards of research excellence, leadership, and societal impact. His contributions to colorectal cancer genetics, DNA mismatch repair research, and cancer health disparities are not only scientifically rigorous but also clinically transformative. As a widely respected physician-scientist, educator, and health equity advocate, he represents the ideal blend of scholarly productivity and service to humanity. Despite minor opportunities for expanding the global and technological dimensions of his work, Dr. Carethers’s achievements place him in the top tier of biomedical researchers. His continued dedication to both advancing science and closing health outcome gaps aligns perfectly with the spirit of the Best Researcher Award. He is not only deserving of this honor but also serves as an inspiring model for current and future generations of researchers.

Dukagjin Blakaj | Radiation Oncology | Best Researcher Award

Published on by Cell Biologist

Prof. Dukagjin Blakaj | Radiation Oncology | Best Researcher Award

Prof. Dukagjin Blakaj, The Ohio State University, United States

Dr. Dukagjin M. Blakaj, MD, PhD, is a distinguished physician-scientist and academic leader in radiation oncology, specializing in proton therapy. Currently serving as the Vice Chair of Clinical Operations and holding the prestigious Drs. Malati and Ganesh Potdar Endowed Professorship at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital, he brings visionary leadership in patient-centered oncology care. With dual degrees in medicine and biochemistry, Dr. Blakaj integrates clinical expertise with advanced translational research. He is renowned for developing innovative radiotherapy protocols, advancing artificial intelligence applications in oncology, and mentoring future clinician-scientists. His work significantly influences treatment outcomes for head and neck cancers, including HPV-related oropharyngeal cancer, and is published in top-tier journals. A respected thought leader and collaborative partner, Dr. Blakaj embodies excellence in academic medicine, multidisciplinary team leadership, and compassionate patient care.

Publication Profile: 

Google Scholar

Scopus

Orcid

Education:

Dr. Blakaj’s educational path is both extensive and interdisciplinary. He earned his MD, PhD, and MS in Biochemistry from the Albert Einstein College of Medicine in New York, where he focused on molecular interactions in biological systems. Before that, he completed both a BA in Chemistry and Molecular Biology & Biophysics and an MA in Chemistry from Wesleyan University in Middletown, CT. His doctoral work explored protein-RNA interactions, laying the groundwork for his scientific rigor and precision. This strong biochemical foundation supports his innovative clinical research in radiation oncology and immunotherapy. His education highlights a consistent pattern of academic excellence and intellectual curiosity, equipping him with a rare blend of clinical insight and research acumen that continues to impact cancer treatment paradigms worldwide.

Professional Experience:

Dr. Dukagjin Blakaj is the Vice Chair of Clinical Operations in Radiation Oncology and Drs. Malati and Ganesh Potdar Endowed Professor in Proton Therapy at OSUCCC – James Cancer Hospital. As a senior faculty member, he has led transformative improvements in clinical care, quality assurance, and translational oncology research. His multidisciplinary collaboration extends across surgery, radiology, oncology, and data science, driving innovations such as AI-guided treatment protocols and digital health integration. Dr. Blakaj has also played a critical role in operationalizing proton therapy and implementing personalized cancer therapies. His background spans high-impact clinical trials, program development, and mentorship. The combination of clinical leadership and academic scholarship positions him as a strategic thinker with practical, evidence-driven execution. His commitment to precision medicine and patient-centered care distinguishes him among modern radiation oncologists.

Awards and Honors:

Dr. Blakaj has received numerous accolades that reflect his clinical excellence, research innovation, and service to the academic community. Notably, he was awarded the Drs. Malati and Ganesh Potdar Endowed Professorship in Radiation Oncology – Proton Therapy (effective June 2025), the highest honor granted by Ohio State University. His ABR Volunteer Service Award (July 2025) highlights his contributions to professional standards and education. He was selected for the James Outstanding Physician Peer Award for exemplary leadership, professionalism, and collaboration (August 2024). Additionally, his abstract ranked in the Top 7 of 146 presentations at ACRO, underscoring his research’s national impact. Dr. Blakaj’s consistent recognition across service, research, and teaching is a testament to his dedication, integrity, and influence in the field of oncology.

Research Focus:

Dr. Blakaj’s research is centered on optimizing cancer treatment outcomes through precision radiation therapy, immunotherapy integration, and the application of artificial intelligence in oncology. He focuses primarily on head and neck cancers, with additional emphasis on HPV-associated oropharyngeal carcinoma, FLASH radiotherapy, and treatment response prediction using circulating tumor DNA and inflammatory indices. He co-leads interdisciplinary studies leveraging machine learning, big data, and digital health tools to personalize care and reduce treatment toxicity. His research is both translational and clinically grounded, often influencing national clinical practice guidelines and multi-center trials. As a key contributor to high-impact publications, Dr. Blakaj has established himself as a thought leader in adaptive radiotherapy and survivorship outcomes. His pioneering work in proton therapy protocols and patient-reported outcomes continues to bridge the gap between innovative science and practical oncology care.

Publications Top Notes: 

  1. An integrated ML-based prognostic model in head and neck cancer using inflammatory markers and financial toxicity

  2. Vertebral endplate disruption and compression fracture risk: Expanded radiotherapy analysis

  3. Nasopharyngeal carcinoma in nonendemic regions: Characteristics and treatment outcomes

  4. Emerging paradigms in radiation oncology: Evolution and patient-centric care

  5. FLASH radiotherapy: From in vivo data to clinical translation

  6. Digital health tools in radiation oncology: Development and implementation review

  7. ctDNA as a response marker in HPV-associated oropharyngeal carcinoma: A pilot study

  8. AI, machine learning, and big data in radiation oncology

  9. Predicting cisplatin tolerability in elderly head and neck cancer patients

  10.  Tobacco, marijuana, and alcohol use impact on survival in metastatic head and neck cancer

Conclusion:

Dr. Dukagjin M. Blakaj is a highly qualified, forward-thinking researcher whose body of work exemplifies excellence in translational oncology. He brings together advanced clinical practice, cutting-edge research, and visionary leadership to improve cancer care outcomes and drive future innovations in radiation therapy.

Given his sustained productivity, multidisciplinary leadership, and contributions to patient-centered care models, Dr. Blakaj is a deserving and outstanding nominee for the Best Researcher Award.

Chetan Shinde | Genetics and Plant Breeding | Young Scientist Award

Published on by Cell Biologist

Mr. Chetan Shinde | Genetics and Plant Breeding | Young Scientist Award

Mr. Chetan Shinde, Mahatma Phule Krishi Vidyapeeth, Rahuri, India

Mr. Shinde Chetan Subhash is a dedicated and passionate agricultural researcher from India with a strong academic foundation and significant contributions to plant genetics and breeding. Known for his positive thinking, excellent presentation skills, and remarkable stage courage, he has demonstrated leadership from his undergraduate days, including his involvement in NSS and technical councils. With a keen interest in crop improvement and biotechnology, Mr. Shinde has co-authored two books and published over 15 peer-reviewed research articles in reputed journals. His work focuses on genetic diversity, molecular characterization, and breeding strategies for crops like soybean, rice, and millet. He shows great promise as a young scientist committed to advancing agricultural innovation. His academic excellence, practical exposure, and publication record make him a valuable contributor to the scientific community.

Publication Profile: 

Google scholar

Strengths for the Award:

  1. Outstanding Academic Performance

    • Secured 89.60% in M.Sc. (Agri.) and 88.70% in B.Sc. (Agri.), both with First Class Distinction from prestigious institutes under Mahatma Phule Krishi Vidyapeeth, Rahuri.

  2. Robust Research Publication Profile

    • Co-authored 15+ research articles in reputed, peer-reviewed national and international journals.

    • Authored 2 academic books on Plant Breeding and Genetics and Biotic Stress Resistance, published by respected publishers.

  3. Diverse and Applied Research Focus

    • Research spans crop improvement, genetic diversity, molecular marker-assisted selection, stress resistance, and microbial consortia, with applications to rice, soybean, pearl millet, finger millet, and moringa.

  4. Technical and Leadership Engagement

    • Served as an NSS volunteer and participated in rural development activities.

    • Member of the All India Council for Technical Skill Development, reflecting commitment to national agricultural capacity building.

  5. Professional Strengths

    • Demonstrates positive thinking, presentation skills, and stage courage—key traits for academic dissemination and leadership in research.

Areas for Improvement:

  1. Global Exposure & Collaborations

    • Can benefit from engaging in international conferences, research networks, or joint publications to enhance global scientific presence.

  2. Advanced Data Analytics

    • Opportunity to deepen skills in bioinformatics, genomics data analysis, and AI applications in plant breeding for future-ready research.

  3. Research Commercialization or Field Application

    • Encouraged to explore technology transfer, patent filings, or on-ground trials that connect his research to real-world farming outcomes.

Education:

Mr. Shinde Chetan Subhash holds an M.Sc. (Agri.) in Genetics and Plant Breeding (2022) from the College of Agriculture, Pune, under Mahatma Phule Krishi Vidyapeeth, Rahuri, securing 89.60% with first class distinction. He earned his B.Sc. (Agri.) in 2020 from Shramashakti College of Agriculture, Maldad, also affiliated with MPKV Rahuri, graduating with 88.70% and first class with distinction. His strong academic record is complemented by active co-curricular participation, including serving as an NSS volunteer and engaging in technical skill development activities. Throughout his academic career, he has consistently excelled in both theoretical and practical aspects of agricultural science. His education has laid a solid foundation for his current research pursuits in crop genetics, plant breeding, and biotechnology, with a specific interest in improving genetic traits and addressing challenges related to biotic stress in crops.

Experience:

Mr. Shinde has an impressive background in both academic and applied agricultural research. During his M.Sc. and B.Sc. studies, he gained hands-on experience in field trials, molecular marker analysis, and statistical evaluation of crop performance. His involvement in multiple research projects has allowed him to collaborate with reputed scientists across India. He has actively participated in NSS rural development programs and is a member of the All India Council for Technical Skill Development. Mr. Shinde’s practical experience is evident from his diverse publication portfolio, including topics on genetic variability, microbial consortia, land use implications, and drought tolerance in crops. His contributions span both classical breeding techniques and modern molecular tools. He has also co-authored two books on plant breeding and biotic stress resistance, showcasing his versatility and scholarly engagement. He is well-prepared for independent research and future leadership in plant science innovation.

Research Focus:

Mr. Shinde’s research is centered on Genetics and Plant Breeding, with an emphasis on improving crop performance under stress conditions. His work spans molecular characterization, development of microbial consortia for nutrient management, and genetic diversity analysis in major crops like rice, soybean, pearl millet, drumstick, and finger millet. He utilizes classical breeding methods and integrates modern biotechnological approaches, including marker-assisted selection. His interest in drought tolerance, biotic stress resistance, and sustainable crop productivity addresses critical agricultural challenges. Notably, he has contributed to molecular research on Kunitz Trypsin Inhibitor and lipoxygenase genes in soybean, ecological land use dynamics, and nutrient optimization in legumes. Through interdisciplinary collaboration, Mr. Shinde has positioned himself at the forefront of agricultural innovation. His work is aligned with the goals of food security, climate resilience, and genetic conservation. He aspires to contribute further to national and global agricultural research as a young scientist.

Publications Top Notes: 

  1. 📘 Plant Breeding and Genetics: Present Concepts and Approaches – Volume 2 (Book)

  2. 📗 Biotic Stress Resistance in Horticultural Crops (Book)

  3. 📝 Evaluation of Wheat [Triticum aestivum (L.)] Genotypes in Response to Late Sown Conditions

  4. 🌱 Development of Microbial Consortia for Nutrient Supplementation to Chickpea

  5. 🌍 Ecological Implications of Land Use Dynamics in Western Maharashtra

  6. 🌾 Estimation of Genetic Variability in Pearl Millet (Pennisetum glaucum L.)

  7. 🌿 Association of Characters and Path Coefficient Analysis in Fodder Drumstick

  8. 🌾 Evaluation of Genetic Divergence in Rice (Oryza sativa L.) Genotypes

  9. 🧬 Identification of Soybean Segregants for Kunitz and Lipoxygenase Genes via Molecular Markers

  10. 🌱 Genetic Variability Studies in Fodder Drumstick (Moringa oleifera L.)

Conclusion:

Mr. Shinde Chetan Subhash is highly suitable for the Research for Young Scientist Award. His academic excellence, multi-dimensional research contributions, and commitment to agricultural innovation strongly align with the award’s purpose—to encourage and recognize emerging researchers. His work bridges traditional breeding and modern biotechnology with a clear focus on sustainable and productive agriculture.

With continued mentorship and strategic research direction, he holds the potential to become a leading young scientist in India’s agri-biotech and crop improvement ecosystem.

Shima Shafiee | Cell Structure Analysis | Best Researcher Award

Published on by Cell Biologist

Dr. Shima Shafiee | Cell Structure Analysis | Best Researcher Award

Dr. Shima Shafiee, Razi University, Iran

Shima Shafiee is an accomplished Iranian researcher specializing in computer systems architecture and bioinformatics, with a strong focus on machine learning applications in biological data analysis. She recently earned her Ph.D. in Computer Engineering from Razi University, where she focused on predictive modeling of protein-peptide binding interactions. Currently under consideration at the IDEL Lab, Shahid Bahonar University of Kerman, Shima has authored numerous national and international publications. With a rich background in algorithm optimization and artificial intelligence, her research stands at the intersection of computational biology, deep learning, and evolutionary algorithms. Shafiee’s work has contributed to the development of predictive tools in bioinformatics, such as DP-site and SPPPred, and she consistently ranks at the top of her academic cohort. Her ability to integrate traditional computer engineering concepts with advanced biological research makes her a notable candidate for the Best Researcher Award.

Publication Profile: 

Google Scholar

Strengths for the Award:

  1. Strong Academic Foundation
    Dr. Shafiee has a stellar academic record, graduating first in her Ph.D. class at Razi University with a CGPA of 3.77 and a thesis grade of 3.98, under the supervision of respected experts in computer engineering and bioinformatics.

  2. Innovative Interdisciplinary Research
    Her research bridges computer systems architecture, machine learning, and bioinformatics, with notable contributions to protein-peptide binding prediction, a critical domain in drug discovery and computational biology.

  3. High-Impact Publications
    She has published in IEEE/ACM Transactions, Applied Soft Computing, and Methods, reflecting both quality and visibility in international forums. Tools like SPPPred and DP-site demonstrate her practical impact in bioinformatics.

  4. Research Originality and Versatility
    Dr. Shafiee has developed hybrid models combining genetic programming, support vector machines, and deep learning, with practical tools and open-source contributions.

  5. Early Recognition and Outreach
    She has been active in academic dissemination since 2015, with selected papers in national and international conferences, showing early promise and consistency.

  6. Teaching and Mentorship
    Through her roles as a lecturer at multiple institutions, she has contributed to academic growth at the grassroots level.

Areas for Improvement:

  1. International Collaboration & Visibility
    While her publication quality is strong, Dr. Shafiee could expand her global visibility through collaborations with international research labs, EU Horizon, or NIH-funded projects.

  2. Post-Ph.D. Grant Applications
    She could benefit from applying for independent research grants or postdoctoral fellowships to lead projects that could shape the future of AI in biology.

  3. Open-Source Software and Data Availability
    While her models are impactful, increased accessibility via open-source repositories (e.g., GitHub) would boost reproducibility and encourage broader adoption.

  4. Industry Impact Metrics
    More emphasis on industry collaborations, patents, or application of models in clinical/biotech settings would enhance translational impact.

Education:

Shima Shafiee completed her Ph.D. in Computer Engineering (2016–2024) from Razi University, specializing in Computer Systems Architecture. Her dissertation titled “Application of learning-based models in predicting of protein-peptide binding interactions” earned her a thesis grade of 3.98/4.00 and an overall CGPA of 3.77. She worked under the guidance of Dr. Abdolhossein Fathi and Dr. Ghazaleh Taherzadeh, focusing on bioinformatics using deep learning, ensemble learning, and evolutionary algorithms. Prior to her Ph.D., she was ranked third in her Master’s program (2015). Shafiee’s educational background is rooted in computational problem-solving, algorithm development, and cross-disciplinary research involving biological data. Her consistent academic excellence and high-ranking performance culminated in her being recognized as the top Ph.D. student in 2025, a testament to her dedication and scholarly capabilities. Her education blends rigorous theory with innovative applied research, making her exceptionally well-prepared for high-impact contributions in academia and industry.

Experience:

Shima Shafiee’s experience spans both academic and applied computer engineering roles. She began her journey with an internship at Kimia Pardaz Pars Company (2013). Between 2015 and 2016, she served as a lecturer for computer fundamentals at Fajr High School and Al-Zahra Seminary School in Jiroft, where she taught introductory computer science to pre-university students. These experiences highlight her foundational teaching skills and outreach to educational institutions in her community. Her major academic contribution began during her Ph.D., where she collaborated with IDEL Lab and contributed to developing tools like SPPPred and DP-site, combining genetic programming, support vector machines, and deep learning to predict protein-peptide binding regions. Her experience uniquely blends educational outreach, algorithmic development, and publication-driven research in machine learning, optimization, and computational biology, reflecting her versatility and impact across the scientific and academic spectrum.

Awards & Honors:

Shima Shafiee has earned multiple distinctions recognizing her academic and research excellence. In 2015, she was named the third-place student in her Master’s program, demonstrating early academic excellence. Her continuous dedication to research and scholarship led her to be recognized as the first-place student in her Ph.D. program in 2025. One of her papers was selected at the 2nd International Congress of Electrical Engineering, Computer Science, and Information Technology (2015), highlighting the innovation and relevance of her early research in optimization algorithms. Her high publication output, including appearances in top-tier venues like IEEE/ACM Transactions on Computational Biology and Bioinformatics and Applied Soft Computing, reflects a consistent standard of excellence. These honors collectively showcase her as a standout figure in her field, with both academic and applied contributions acknowledged at national and international levels.

Research Focus:

Shima Shafiee’s research lies at the intersection of machine learning, bioinformatics, and computational systems engineering. Her primary focus is the prediction of protein-peptide binding interactions using intelligent algorithms such as genetic programming, ensemble models, and deep learning techniques. She has proposed several innovative hybrid models combining sequence-based and structure-based features to identify critical interaction residues. Her doctoral thesis and publications have led to the development of tools like SPPPred and DP-site, which aid in biological sequence analysis, with applications in drug discovery, protein function prediction, and biomedical engineering. Shafiee also has a strong background in optimization algorithms, especially particle swarm optimization (PSO), applied to computationally intensive problems like bin packing. Her ability to blend theoretical computing with practical biological data analysis makes her contributions valuable to both computational scientists and biologists, and positions her as a leading candidate for research recognition awards in AI and bioinformatics.

Publications Top Notes: 

  • 🧠 SPPPred: sequence-based protein-peptide binding residue prediction using genetic programming and ensemble learning (IEEE/ACM TCBBS, 2022)

  • 🔍 Prediction of protein–peptide-binding amino acid residues regions using machine learning algorithms (CSICC, 2021)

  • 🧬 Combination of genetic programming and SVM-based prediction of protein-peptide binding sites (Journal of Computing and Security, 2021)

  • 🧪 Prediction of protein–peptide binding residues using classification algorithms (IEEE Bioengineering Conf, 2020)

  • 🧠 A Review of the Uses of AI in Protein Research (Peptide Science Conf, 2019)

  • 🤖 DP-site: dual deep learning method for protein-peptide interaction site prediction (Methods, 2024)

  • 🧬 Protein-peptide interaction region prediction using generative sampling & ensemble DL (Applied Soft Computing, 2025)

  • 🧠 Comparing classification vs. segmentation predictors in protein-peptide interaction (CSICC, 2025)

  • 🧬 Leveraging structure-based and learning-based predictors in protein-peptide interaction (ICCKE, 2024)

  • 📘 Application of learning-based models in protein-peptide binding (Ph.D. Dissertation, 2024)

Conclusion:

Dr. Shima Shafiee is a highly suitable candidate for the Best Researcher Award based on her academic excellence, interdisciplinary research achievements, and consistent contributions to the fields of artificial intelligence and bioinformatics. Her ability to bridge computer science and biological challenges has resulted in meaningful and applicable solutions. She has displayed originality, depth, and foresight in her work, developing novel methods that align with modern computational biology trends.

Sukanta Nath | Cancer Research | Distinguished Scientist Award

Published on by Cell Biologist

Dr. Sukanta Nath | Cancer Research | Distinguished Scientist Award

Dr. Sukanta Nath, Atal Bihari Vajpayee Regional Cancer Centre, India

Dr. Sukanta Nath is a dedicated Research Scientist with over 13 years of experience in molecular biology, virology, and cancer research. He currently serves at the Atal Bihari Vajpayee Regional Cancer Centre, Agartala, Tripura, where he has led several impactful studies in oral cancer patient care. Holding a Ph.D. in Biotechnology from Gauhati University, Dr. Nath has consistently demonstrated excellence in scientific inquiry, especially in clinical intervention studies. His collaborative works with clinical and academic experts have produced over 10 peer-reviewed publications in reputed journals. Dr. Nath’s research emphasizes evidence-based nursing practices, molecular diagnostics, and the improvement of post-surgical outcomes in cancer patients. Known for his commitment to translational research, Dr. Nath is playing a pivotal role in bridging molecular science with patient-centered care in North-East India. His multidimensional expertise and scholarly contributions make him a deserving candidate for recognition as a Distinguished Scientist.

Publication Profile: 

Scopus

Strengths for the Award:

  1. Extensive Research Experience:
    With over 13 years of hands-on experience in molecular biology, cancer research, and virology, Dr. Nath has a well-established research career that aligns with the award’s standards.

  2. Focused Contributions to Cancer Research:
    His work at Atal Bihari Vajpayee Regional Cancer Centre has significantly contributed to oral cancer patient management, particularly through randomized intervention studies improving postoperative recovery and mental health.

  3. High Research Output:
    He has authored or co-authored 10+ peer-reviewed publications, many of which focus on novel and under-explored aspects such as nursing intervention in cancer care—a progressive and human-centered approach.

  4. Multidisciplinary Approach:
    Dr. Nath bridges molecular diagnostics, clinical research, and public health, evident in his work on HPV molecular epidemiology and AML treatment reviews.

  5. Collaborative and Institutional Impact:
    His collaborations with clinicians, nurses, and academic institutions highlight his team-oriented and translational research vision, helping integrate academic outputs into real-world healthcare.

Areas for Improvement:

  1. International Exposure:
    Dr. Nath could enhance his academic profile with international fellowships, collaborative projects, or presentations at global conferences, which would add broader recognition and perspective to his impactful regional work.

  2. Grant Acquisition & Leadership Roles:
    Documented principal investigator roles or research funding/grant awards would strengthen his leadership credentials in scientific research.

  3. Recognition & Awards:
    While he has a commendable publication record, more national or state-level recognitions, fellowships, or memberships in professional bodies (like ICMR, DBT, etc.) would boost his candidacy for national-level honors.

Education:

Dr. Sukanta Nath’s academic foundation is rooted in the biological sciences, beginning with a B.Sc. in Botany, Zoology, and Physiology from Calcutta University (2003, First Class). He went on to complete his M.Sc. in Biotechnology from Utkal University in 2006, securing First Class (67%). His research potential culminated in a Ph.D. in Biotechnology from Gauhati University, awarded in 2018, where he specialized in molecular biology and translational biomedical science. His education reflects a progressive mastery of theoretical and applied biotechnology, allowing him to engage in complex interdisciplinary research. Despite modest early academic challenges in higher secondary and matriculation, Dr. Nath’s academic trajectory sharply ascended, reflecting perseverance and intellectual growth. His doctoral training equipped him with specialized skills in molecular diagnostics, research design, and bioanalytical tools, which now form the backbone of his professional research work in cancer and infectious disease.

Professional Experience:

Dr. Nath is presently serving as a Research Scientist at the Atal Bihari Vajpayee Regional Cancer Centre, Tripura, since April 2020, where he conducts pivotal research on postoperative outcomes and interventions in oral cancer patients. Previously, he worked as a Research Associate at the College of Fisheries, Central Agricultural University, Tripura (2018–2019), contributing to institutional-level biotech projects. In 2017–2018, he served as a Molecular Scientist and Quality Manager at Agility Diagnostics Pvt. Ltd., Delhi, a NABL-accredited molecular diagnostics lab, where he gained valuable experience in molecular testing and lab quality control. With over 13 years of interdisciplinary experience, Dr. Nath has successfully combined clinical and molecular biology expertise, making impactful contributions to oncology, diagnostics, and public health. His adaptability across academic, clinical, and industry environments illustrates his wide-ranging capabilities as a biomedical researcher and project leader.

Awards and Honors:

While specific named awards are not listed in the provided resume, Dr. Sukanta Nath’s contributions have earned peer recognition through frequent lead and co-author roles in high-impact publications. His ongoing collaboration with clinicians, epidemiologists, and nursing researchers has positioned him as a sought-after expert in cancer-related intervention studies in North-East India. He has been an instrumental figure in pioneering randomized clinical studies assessing fatigue, anxiety, and quality of life in post-surgical oral cancer patients—work that has been accepted in internationally indexed journals. His contributions to the molecular epidemiology of HPV in Indian women also reflect national relevance. The volume and scope of his work, alongside a sustained publication record, underline a distinguished career in translational cancer research. Nomination for the Distinguished Scientist Award is a well-aligned recognition of his achievements and continued potential to contribute at the national level.

Research Focus:

Dr. Nath’s primary research interest lies in molecular biology, oncology, and virology, with a strong emphasis on translational studies that impact patient care. He has led intervention-based research evaluating the role of nursing and clinical protocols in improving postoperative recovery among oral cancer patients. His work assesses anxiety, fatigue, and quality of life post-surgery using evidence-based methodologies. Dr. Nath has also contributed significantly to molecular epidemiology, particularly studying the distribution of high-risk HPV genotypes among women in North-East India. His experience in diagnostics and biotech allows him to approach clinical problems from both biomedical and molecular perspectives, making his research integrative and impactful. The focus on nursing intervention studies, rarely explored in Indian cancer centers, demonstrates his commitment to holistic cancer care. His future goals involve scaling such studies to wider patient populations and contributing to national cancer care protocols.

Publications Top Notes:

  1. 📘 Effectiveness of a supportive educational intervention on pain and physical function among patients undergone abdominal surgery: A randomized controlled trial

  2. 📗 Effectiveness of comprehensive nursing intervention on alleviating postoperative fatigue and anxiety in patients with oral cancer

  3. 📕 Molecular epidemiology and genotype distribution of genital high-risk human papillomavirus among women in North–East India

  4. 📙 Effectiveness of Nursing Interventions on Anxiety among Postoperative Oral Cancer Patients in Regional Cancer Centre, Tripura

  5. 📒 Importance of Nursing Intervention in Alleviating Post-Surgical Fatigue for Patients with Oral Cancer

  6. 📓 Does comprehensive nursing intervention improve post-surgical anxiety in patients with oral cancer?

  7. 📔 Post-Surgical Evaluation of Quality of Life in Patients with Oral Cancer: An Intervention Study from India

  8. 📚 Assessment of Fatigue and Quality of Life amongst Post-Operative Oral Cancer Patients: A Randomized Case Control Study

  9. 📙 Effect of Comprehensive Nursing Intervention on Anxiety and Quality of Life in Postoperative Patients with Oral Cancer

  10. 📗 Prognosis and Treatment in Acute Myeloid Leukemia: A Comprehensive Review

Conclusion:

Dr. Sukanta Nath has demonstrated dedicated service, innovative research, and strong scientific output in the fields of molecular biology and oncology, particularly with a patient-centric approach to oral cancer care. His work addresses a critical healthcare challenge in North-East India and proposes practical solutions backed by rigorous research methodologies.

 

Mohammad reza Atashzar | Cancer stem cell | Best Researcher Award

Published on by Cell Biologist

Dr. Mohammad reza Atashzar | Cancer stem cell | Best Researcher Award

Dr. Mohammad reza Atashzar, Dep of immunology, Fasa university of medical sciences ( FUMS ), Iran

Dr. Mohammad Reza Atashzar is an Assistant Professor in the Department of Immunology at Fasa University of Medical Sciences (FUMS), Iran. With an enduring passion for tumor immunology, stem cells, vaccine design, and immunotherapy, he has made significant contributions through both basic and translational research. Dr. Atashzar earned his PhD in Immunology from Shahid Beheshti University of Medical Sciences and has since engaged in teaching, mentoring, and publishing extensively in high-impact journals such as The Lancet Oncology, Frontiers in Immunology, and Current Molecular Medicine. His innovative research spans exosome-based therapy, cancer biomarkers, cytokine profiling, and radiogenomics. Dr. Atashzar has also contributed to international collaborations across Germany, Finland, and the UK, showcasing a global outlook in biomedical science. An awardee of the KAI 2022 International Travel Grant and recognized as the Top Researcher at FUMS in 2021, he remains deeply committed to advancing immunological sciences for clinical and therapeutic benefit.

Publication Profile: 

Orcid

Google Scholar

✅ Strengths for the Award:

  1. Extensive Research Contributions
    Dr. Atashzar has authored numerous peer-reviewed publications in reputable journals including The Lancet Oncology, Frontiers in Immunology, Current Molecular Medicine, and Computers in Biology and Medicine. His work spans critical fields like cancer immunology, exosome therapy, stem cell immunomodulation, and vaccine research.

  2. High-Impact Publications
    Several of his papers have significant citation counts—556 for Frontiers in Immunology, 284 for Journal of Cellular Physiology, and 207 for The Lancet Oncology, reflecting strong influence and relevance in the scientific community.

  3. International Recognition and Collaborations
    He has participated in international conferences (UK, China, Korea, Denmark, Spain, Italy) and collaborated with global institutions such as the University of Helsinki, University of Kiel, and GBD Collaborators, demonstrating a global research footprint.

  4. Innovation and Patents
    He has contributed to translational science through a published book on immunopharmacology and a pending patent for a microbiology loop sterilizer device, showing practical application of his research.

  5. Awards and Editorial Involvement
    Recognized with the International Travel Award (KAI 2022) and Top Researcher of FUMS (2021), and serving on editorial boards of scientific journals—further affirming his active role in academic development and peer review.

  6. Interdisciplinary Research Scope
    His research merges clinical immunology, oncology, AI-based prognostic tools, and cellular therapy, making his work not only innovative but also future-oriented.

⚠️ Areas for Improvement:

  1. Increase in First or Senior Author Publications
    While his contributions are numerous, strengthening his authorship role in key studies would amplify his recognition as a principal investigator.

  2. Patent Commercialization & Technology Transfer
    Moving from patent design to real-world implementation or licensing could significantly raise the translational value of his research.

  3. Higher Grant Involvement
    More participation in national/international grant-funded programs or consortiums would enhance the scale and visibility of his research.

  4. Focused Research Niche
    Narrowing focus slightly (e.g., prioritizing tumor immunology or exosome-based therapies) could help build a globally recognized brand in a specialized field.

🎓 Education:

Dr. Atashzar completed his undergraduate and master’s studies in Immunology at Shiraz University of Medical Sciences (SUMS), Shiraz, Iran. Building on his foundational expertise, he pursued his PhD in Immunology at Shahid Beheshti University of Medical Sciences, Tehran. His doctoral thesis—“Investigation of the Effects of B16F10 Derived Exosomes Enriched with miRNA-211 in Induction of Antitumor Response in the Mouse Model of Melanoma”—reflected his early interest in cancer immunotherapy and translational research. Throughout his academic journey, Dr. Atashzar displayed a strong inclination toward exploring novel immune pathways and cell-based therapies. His formal education has laid a robust foundation for his ongoing work in immunological sciences, particularly in relation to tumor microenvironment, cytokine profiling, exosomes, and vaccine innovation. He has also undertaken continuous learning through collaborations and international scientific conferences, allowing him to integrate cutting-edge methodologies into his research and teaching repertoire.

🧪 Professional Experience:

Dr. Mohammad Reza Atashzar currently serves as an Assistant Professor of Immunology at Fasa University of Medical Sciences, with additional teaching responsibilities at Larestan University of Medical Sciences. He has accumulated over a decade of experience in academic instruction and biomedical research. His research portfolio includes multiple funded projects, notably in cancer immunology, cytokine regulation, diabetes-related immune responses, and exosome-based therapeutics. Dr. Atashzar has worked closely with international teams in Germany, Finland, and the UK, facilitating interdisciplinary approaches and innovations in clinical immunology. He is an editorial board member for reputed journals such as The International Journal of Neuroscience and Journal of International Medical Research. In parallel, he actively contributes to conference presentations worldwide, covering topics from cancer stem cells to immune biomarkers. His hands-on laboratory experience, combined with a global research network, enables him to lead and mentor in advanced areas like CAR-T cell therapy and personalized immunotherapy.

🧬 Research Focus:

Dr. Atashzar’s research is centered on tumor immunology, exosome-based therapies, cancer stem cells, CAR-T cell technology, cytokine profiling, and immunopharmacology. He has a keen interest in how immune cells—particularly T cells, NK cells, and regulatory B cells—can be harnessed for cancer therapy. His notable projects have explored the immunomodulatory effects of miRNA-enriched exosomes, the role of TLR4 polymorphisms in diabetes, and cytokine alterations in addiction and radiation-exposed individuals. He is also pioneering in translational research areas such as vaccine design, radiogenomics, and bio-immune device development. Dr. Atashzar integrates bioinformatics and machine learning for predictive modeling, evident in his contributions to COVID-19 prognostic modeling using CT radiomics. His work is driven by the goal of personalized immunotherapy and the identification of novel biomarkers for cancer progression and immune regulation. Through interdisciplinary collaborations, he aims to bridge the gap between immunological research and clinical application.

📚 Publications Top Notes:

  1. 🧬 Cancer stem cells: A review from origin to therapeutic implications – Journal of Cellular Physiology

  2. 🧪 Tumor‐Derived Exosomes Enriched by miRNA‐211a Promote Antitumor Immune Response in B16F10 Tumor‐Bearing Mice – APMIS

  3. 🔬 The effects of tumor-derived exosomes enriched with miRNA-211a on B16F10 cells – Contemporary Oncology

  4. 💉 The effects of type 2 diabetes mellitus on organ metabolism and the immune system – Frontiers in Immunology

  5. 🧠 Pyrin and hematopoietic interferon-inducible nuclear protein domain proteins: innate immune sensors for cytosolic and nuclear DNA – Critical Reviews in Immunology

  6. 🧪 Reduced levels of T-helper 17-associated cytokines in serum of breast cancer patients – Central European Journal of Immunology

  7. 🧫 The Role of IL‐6, IL‐10 and CRP in Gastrointestinal Cancers – Cell Biology International

  8. 🌍 The global burden of adolescent and young adult cancer in 2019 – The Lancet Oncology

  9. 🖥️ COVID-19 prognostic modeling using CT radiomic features and ML algorithms – Computers in Biology and Medicine

  10. 🌡️ Mesenchymal stromal cells in bone marrow niche of multiple myeloma – Cancer Cell International

📌 Conclusion:

Dr. Mohammad Reza Atashzar is highly suitable for the Best Researcher Award. His body of work reflects a deep commitment to scientific advancement in cancer immunology, immunotherapy, and bio-innovation. He combines strong academic output with international engagement, cross-disciplinary impact, and teaching contributions. With growing influence in both research and translational domains, Dr. Atashzar is poised to further elevate biomedical research in Iran and globally.

Nabil Alshurafa | Molecular Mechanisms Signaling | Best Researcher Award

Published on by Cell Biologist

Prof. Nabil Alshurafa | Molecular Mechanisms Signaling | Best Researcher Award

Prof. Nabil Alshurafa, Northwestern University, United States

Dr. Nabil Alshurafa is a tenured Associate Professor at Northwestern University’s Feinberg School of Medicine in the Department of Preventive Medicine. A recognized expert in wearable health technology and artificial intelligence, his work bridges computer science and preventive health. With a strong foundation in AI, embedded systems, and wireless health, Dr. Alshurafa is known for pioneering research that transforms how chronic conditions are monitored remotely. He has held prestigious fellowships, serves on influential editorial boards, and contributes actively to global conferences. Passionate about advancing digital health, his interdisciplinary approach fosters innovation in non-invasive health monitoring technologies. His body of work, including over 100 peer-reviewed publications and several with high citation metrics, has significantly shaped mobile and wearable health sensing technologies. Known for collaborative leadership and visionary research, he continues to inspire advancements in AI-driven healthcare.

Publication Profile: 

Google Scholar

✅ Strengths for the Award:

  1. Innovative Research Focus:
    Dr. Alshurafa is a pioneer in AI-powered wearable health technologies, focusing on practical, non-invasive solutions for chronic disease management, nutrition monitoring, and human activity recognition.

  2. High-Impact Publications:
    His publications are well-cited, including several landmark works like “Deep learning in human activity recognition…” and “NeckSense…” that demonstrate translational value in digital health and mobile sensing.

  3. Prestigious Roles & Affiliations:
    Editorial roles with ACM IMWUT, IEEE, and Nature Digital Medicine, along with organizational roles in IEEE PerCom, underscore his peer recognition and leadership in the field.

  4. Award-Winning Work:
    His research has received Best Paper Awards and has been presented at highly selective conferences with acceptance rates as low as 10–25%.

  5. Interdisciplinary Impact:
    His work intersects computer science, biomedical engineering, and preventive medicine, which is critical in tackling modern healthcare challenges through integrated technology.

  6. Real-World Applications:
    Tools like WANDA, NeckSense, and smart bedsheets reflect direct applicability to patient care and wellness monitoring.

🔧 Areas for Improvement:

  1. Global Visibility:
    While his national recognition is strong, increasing presence in international healthcare policy and standards bodies could elevate his global influence.

  2. Cross-Sector Translation:
    Although academically impactful, more visible industry collaborations or commercial deployments (e.g., FDA-approved products or spin-offs) would enhance the translational credibility of his work.

  3. Public Engagement:
    Expanding outreach through public talks, tech-for-health summits, or popular science channels would help bring his innovations closer to everyday users and clinicians.

  4. Broader Health Diversity Applications:
    More research could be targeted toward underserved populations or global health settings, showcasing scalability and equity of the solutions.

🎓 Education:

Dr. Nabil Alshurafa began his academic journey at the University of California, Los Angeles (UCLA), earning a Bachelor of Science in Computer Science in 2003 with summa cum laude honors. He further pursued graduate education at UCLA, receiving his Master of Science in Computer Science in 2010 with a specialization in Artificial Intelligence. His graduate work laid the foundation for his future contributions in AI-powered healthcare. To gain applied research experience, he joined UCLA’s Wireless Health Institute from 2013 to 2015 as a Wireless Health Fellow. This multidisciplinary training equipped him with expertise in sensor technology, machine learning, and biomedical systems. The academic rigor and technological immersion at UCLA played a pivotal role in shaping his research direction—particularly in remote health monitoring and ubiquitous computing, which have become the hallmarks of his career.

🧪 Experience:

Dr. Alshurafa’s career spans academia, research, and editorial leadership. Since 2022, he has served as a tenured Associate Professor at Northwestern University, where he leads innovative projects in wearable computing and health analytics. His prior fellowship at UCLA’s Wireless Health Institute (2013–2015) was instrumental in honing his applied skills in biomedical sensing and embedded AI systems. He has contributed to multiple high-impact research studies, demonstrating leadership in both collaborative and solo research environments. Beyond teaching and mentoring, Dr. Alshurafa plays a key role in global health informatics networks, serving on editorial boards such as ACM IMWUT, PLOS ONE, and Nature Digital Medicine. His industry engagement is evident from his organizational roles at IEEE PerCom, where he has served as Industry Track Chair and Sponsorship Chair. These roles reflect his commitment to bridging academia with real-world technological solutions in preventive and mobile health.

🏅 Awards and Honors:

Dr. Alshurafa has been recognized for his academic excellence and leadership in health informatics. He is a member of ACM and has held key editorial positions in ACM Interactive, Mobile, Wearable, and Ubiquitous Computing (IMWUT). His roles with IEEE PerCom as Industry Track Chair (2018) and Sponsorship Chair (2019) highlight his prominence in mobile health computing communities. His research has been distinguished with honors such as Best Paper Award at the IEEE International Conference on Wearable and Implantable Body Sensor Networks (BSN). Additionally, several of his publications have been widely cited, underscoring his influence in the field. His editorial board memberships across journals like PLOS ONE, IEEE Biomedical Health Informatics, and Nature Digital Medicine showcase peer recognition of his expertise. Collectively, these accolades reflect a sustained and impactful contribution to health technologies and interdisciplinary research.

🔬 Research Focus:

Dr. Nabil Alshurafa’s research centers on AI-driven wearable technologies for remote health monitoring and behavioral health sensing. He focuses on building unobtrusive, sensor-based systems that can track physiological signals and behaviors such as eating, physical activity, and sleep in real-world environments. By integrating machine learning with low-power embedded systems, he develops scalable tools for chronic disease management, including heart failure and diabetes. His work leverages signal processing, stochastic modeling, and deep learning to transform raw sensor data into clinically actionable insights. A key contribution is his development of NeckSense, a multi-sensor necklace for detecting eating behaviors, and WANDA, an end-to-end health monitoring system. Through interdisciplinary collaborations, he also explores nutrition sensing, exergaming, and rehabilitation technologies. His ultimate goal is to enable proactive, personalized healthcare solutions that reduce the burden on patients and providers alike while enhancing wellness through smart, wearable ecosystems.

📚 Publications Top Notes: 

  1. 🕷️ Artificial Spider: Eight-legged arachnid and autonomous learning of locomotion

  2. ❤️ WANDA: An end-to-end remote health monitoring and analytics system for heart failure patients

  3. 🔋 Opportunistic hierarchical classification for power optimization in wearable movement monitoring systems

  4. 🩺 Dynamic task optimization in remote diabetes monitoring systems

  5. 😴 Inconspicuous on-bed respiratory rate monitoring

  6. 🛏️ A dense pressure sensitive bedsheet design for unobtrusive sleep posture monitoring

  7. 👕 Improving accuracy in E-Textiles as a platform for pervasive sensing

  8. 🚶 Robust human intensity-varying activity recognition using Stochastic Approximation in wearable sensors

  9. 🏋️ On-bed monitoring for range of motion exercises with a pressure sensitive bedsheet

  10. 🎮 MET calculations from on-body accelerometers for exergaming movements

🧾 Conclusion:

Dr. Nabil Alshurafa stands out as an exceptionally qualified candidate for the Best Researcher Award. His work embodies the intersection of innovation, application, and societal benefit. He has demonstrated leadership in both research productivity and community contribution, with a track record that is not only prolific but also highly relevant to the future of preventive and digital healthcare. His pioneering systems in wearable health monitoring have the potential to transform how health is tracked and managed in real time, offering personalized insights and clinical utility.

Abdulatif AL-Haj | Cytoskeleton Cell Motility | Innovative Research Award

Published on by Cell Biologist

Dr. Abdulatif AL-Haj | Cytoskeleton Cell Motility | Innovative Research Award

Dr. Abdulatif AL-Haj | Ruhr Universität Bochum | Germany

Dr. Abdulatif Al Haj is a highly accomplished biochemist and molecular cardiology researcher originally from Syria, currently residing in Germany. With extensive academic and professional experience across Europe and the Middle East, Dr. Al Haj has built a multidisciplinary career in molecular biology, biotechnology, and medical education. He holds a doctorate in biology and biotechnology, with a strong focus on actin dynamics and cardiovascular disease. Fluent in Arabic, German, English, and French, he has effectively bridged scientific research with public health, education, and social integration roles. His work includes teaching, paramedic service during the pandemic, and involvement in migrant integration and healthcare initiatives. He has contributed to peer-reviewed publications and collaborated with notable researchers in Germany. Dr. Al Haj exemplifies international scientific cooperation and interdisciplinary application of biosciences for societal benefit.

publication profile:

scopus

🔍 Strengths for the Award:

  • 🔬 Cutting-Edge Research: Key discoveries in actin cytoskeleton regulation and thymosin beta4′s role in cardiac repair

  • 🌍 Global Impact: Extensive collaborations in Germany and Syria, advancing both education and research

  • 📚 Scientific Output: Author of multiple high-impact journal articles and presenter in international scientific symposia

  • 👨‍🏫 Cross-disciplinary Excellence: Combines life sciences, education, and healthcare

  • 🧪 Innovative Thinking: Integrated research on cofilin/ADF, Arp2/3 complex, and cardiomyocyte remodeling

🚧 Areas for Improvement:

  • Broader dissemination of findings through more international conferences

  • Increase involvement in grant-funded principal investigator (PI) roles

  • Enhance digital presence via scientific networking platforms (e.g., ResearchGate, ORCID)

🎓 Education :

Dr. Al Haj earned his diploma and Master’s degrees in Biotechnology and Biochemistry from the University of Damascus, Syria. He later completed a Doctorate in Biology and Biotechnology with a dissertation on the modulation of cofilin/ADF and thymosin beta4 in cell migration. His academic pursuits also include studies in Educational Planning, Natural Sciences, and Microbiology at the Technical University of Applied Sciences Berlin and Ruhr University Bochum. Additionally, he undertook postgraduate training in Education and Psychology, Business English, and quality management under TÜV-certified programs. Dr. Al Haj further enriched his academic repertoire with continuous professional development courses in process management, norm standards (ISO 9001), and nutrition. His commitment to lifelong learning reflects a passion for combining theoretical science with applied clinical and educational practices.

🧪 Experience :

Dr. Al Haj has accumulated extensive research and teaching experience across several prestigious institutions. At the Ruhr University Bochum, he worked with Prof. Hans Georg Mannherz on actin-regulating proteins, contributing to innovative cardiology research. He held posts at Catholic and Central Clinics as a scientist, served as a paramedic at Herne Vaccination Center, and worked as a social worker and integration coach. His academic duties included teaching biology, chemistry, and physics, and serving as an Arabic language teacher in Berlin. Additionally, Dr. Al Haj took on project management and quality assurance roles at LVQ Further Education gGmbH and underwent TÜV training for process management. His unique blend of clinical, educational, and social service roles highlights his commitment to interdisciplinary collaboration and societal contribution.

🔬 Research Focus :

Dr. Al Haj’s research centers on molecular and experimental cardiology, cytoskeletal proteins (cofilin/ADF), and cell migration. His doctoral and postdoctoral work explored the effects of thymosin beta4 and actin-regulating proteins on cellular motility—essential for understanding cardiac development and cancer metastasis. His published work includes significant studies on the Arp2/3 complex, actin dynamics, and the influence of sGC activators on cardiac cells from hypertensive and heart failure patients. Beyond molecular cardiology, he has explored radioimmunoassay techniques, EBV-associated gastric carcinoma, and embryological development of cardiac muscle from branchial arch progenitors. His multidisciplinary approach blends biochemistry, histology, anatomy, and clinical diagnostics, bridging basic research with therapeutic applications. His ongoing interest in student assessment and e-learning underscores a commitment to scientific education and training.

📚 Publications Top Notes :

  1. 🧬 Inhibition of Arp2/3 Complex after ADP-Ribosylation of Arp2 by Binary Clostridioides Toxins – Cells, 2022

  2. ❤️ sGC Activator Causes Beneficial Remodeling in Cardiomyocytes from Hypertensive Rats and Heart Failure Patients – Front. Physiol.

  3. 🧠 Chicken Second Branchial Arch Progenitor Cells Contribute to Heart Musculature In Vitro and In Vivo – Developmental Dynamics, 2020

  4. 🧫 Characteristics of Gastric Carcinoma Associated with Epstein Barr Virus in Algeria – Der Pharmacia Lettre, 2017

  5. 🦴 Etiology and Pathogenesis of Arthrofibrosis at the Cellular Level – Arthroscopy, 2016

  6. 🧪 HeLa Cells and the Human Colon Carcinoma BE, 3LNLN and EB3 Cell Lines – Dissertation Work

  7. 🎓 Research on Assessing Students’ Academic Performance in Bloom’s Cognitive Level

🧾 Conclusion :

Dr. Abdulatif Al Haj is a strong candidate for the Innovative Research Award, distinguished by his relentless pursuit of molecular innovation, interdisciplinary approach, and commitment to public health and education. His work on actin-binding proteins and cardiac regeneration holds promising implications for heart disease treatment and personalized medicine. His track record demonstrates scientific creativity, rigor, and societal relevance.